SCHEMBL5147134

SCHEMBL5147134

CC(=O)Nc1ccc(-n2c3c(c4ccccc42)C(=O)CCC3)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.45
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
BAZ2B Q9UIF8 1/20 0.43
ESRRA P11474 2/20 0.42
TP53 P04637 1/20 0.41
CREBBP Q92793 1/20 0.41
ALDH1A1 P00352 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ATAD2 Q6PL18 1/20 0.40
CECR2 Q9BXF3 1/20 0.40
BRD4 O60885 1/20 0.40
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
GRM4 Q14833 1/20 0.39
OPRM1 P35372 1/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
MAOB P27338 1/20 0.39
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5148161 0.92 TP53 (0.41) LMNAHDAC1HDAC6BAZ2BESRRA
SCHEMBL5147135 0.90 HDAC1 (0.43) LMNAHDAC1HDAC6TP53CREBBP
SCHEMBL5147107 0.89 CYP2D6 (0.48) LMNAHDAC1HDAC6ESRRAALDH1A1
SCHEMBL5145428 0.87 DOT1L (0.45) HDAC1HDAC6TP53CREBBPPTGS1
SCHEMBL5147078 0.81 HDAC1 (0.48) LMNAHDAC1HDAC6TP53CREBBP
SCHEMBL5148480 0.80 PTGS1 (0.44) LMNAHDAC1HDAC6ALDH1A1PTGS1
SCHEMBL14422443 0.79 TP53 (0.41) LMNAHDAC1HDAC6TP53CREBBP
SCHEMBL4771960 0.79 CYP3A4 (0.43) HDAC1HDAC6TP53CREBBPALDH1A1
SCHEMBL5145359 0.77 GRM4 (0.35) LMNATP53ALDH1A1GRM4KDM4E
SCHEMBL5145355 0.77 GRM4 (0.35) LMNATP53ALDH1A1GRM4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US claimed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
WO-2007035620-A2 CARBAZOLE DERIVATIVES SERENEX, INC. (US) 2007-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185184-A1 Carbazole derivatives CCNI, MKI67, CCNB3 LMNA 3300/4885HDAC1 145/4885HDAC6 204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.